Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.04 (1.50%)
Bid:
2.705
Ask:
2.73
Spread: 0.025 (0.924%)
Market Cap: $8.91b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

3rd Quarter Results - Consolidated

3 Nov 2023 07:05

RNS Number : 2563S
Commercial Intnl Bank (Egypt) SAE
03 November 2023
Β 

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements

Β 

September 30, 2023

Β 

Β 

Β 

Condensed Consolidated Interim Statement of Financial Position as at September 30, 2023

Β 

Notes

Sep. 30, 2023

Β 

Dec. 31, 2022

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Assets

Β 

Β 

Β 

Cash and balances at the central bank

8

59,950,223

Β 

47,492,549

Β 

Due from banks

9

276,842,860

Β 

133,856,720

Β 

Loans and advances to banks, net

11

-

Β 

2,978,197

Β 

Loans and advances to customers, net

12

223,085,568

Β 

193,599,872

Β 

Derivative financial instruments

Β 

1,647,485

Β 

1,939,961

Β 

Financial investments

Β 

Β 

Β 

- Financial Assets at Fair Value through OCI

13

189,098,612

Β 

204,020,733

Β 

- Financial Assets at Amortized cost

13

39,177,670

Β 

34,524,760

Β 

- Investments in associates

14

132,476

Β 

186,062

Β 

Non current assets held for sale

29

214

Β 

-

Β 

Other assets

15

17,375,013

Β 

14,521,427

Β 

Goodwill

26

65,325

Β 

96,268

Β 

Intangible assets

27

-

Β 

24,188

Β 

Deferred tax assets

Β 

1,137,342

Β 

185,746

Β 

Property and equipment

16

2,556,198

Β 

2,405,434

Β 

Total assets

Β 

811,068,986

Β 

635,831,917

Β 

Liabilities and equity

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Due to banks

17

19,022,706

Β 

3,496,698

Β 

Due to customers

18

667,669,213

Β 

531,616,550

Β 

Non current liabilities held for sale

30

933

Β 

-

Β 

Derivative financial instruments

Β 

99,911

Β 

219,752

Β 

Current income tax liabilities

6,993,454

Β 

3,051,583

Β 

Other liabilities

19

15,875,568

Β 

11,606,912

Β 

Issued debt instruments

20

3,071,834

Β 

2,456,607

Β 

Other loans

Β 

10,387,714

Β 

7,978,975

Β 

Other provisions

21

10,511,982

Β 

7,066,672

Β 

Total liabilities

Β 

733,633,315

Β 

567,493,749

Β 

Equity

Β 

Β 

Β 

Β 

Issued and paid up capital

Β 

30,195,010

Β 

29,825,134

Β 

Reserves

Β 

23,007,690

Β 

19,643,327

Β 

Reserve for employee stock ownership plan (ESOP)

Β 

1,339,443

Β 

1,895,435

Β 

Retained earnings *

22,764,552

Β 

16,393,841

Β 

Total equity and net profit for the period / year

77,306,695

67,757,737

Non Controlling Interest

Β 

128,976

Β 

580,431

Β 

Total minority interest, equity and net profit for the period / year

77,435,671

68,338,168

Β 

Total liabilities and equity

811,068,986

635,831,917

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

The accompanying notes are an integral part of these financial statements .

Β 

Β 

(Limited review report attached)

* Including net profit for the current period

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Hussein Abaza

Hisham Ezz Al-Arab

Β 

CEO & Managing Director

Chairman

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Income Statement for the period ended September 30, 2023

Β 

Β 

Β 

Β 

Β 

Β 

Last 9 Months

Β 

Last 9 Months

Notes

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Interest and similar income

73,006,422

Β 

38,938,124

Interest and similar expense

(35,275,583)

Β 

(17,120,373)

Net interest income

Β 

37,730,839

Β 

21,817,751

Β 

Β 

Fee and commission income

6,543,585

Β 

3,908,463

Fee and commission expense

(2,589,680)

Β 

(1,730,281)

Net fee and commission income

Β 

3,953,905

Β 

2,178,182

Β 

Β 

Dividend income

83,653

Β 

54,557

Net trading income

5

3,165,144

Β 

1,434,169

Profits (Losses) on financial investments

13.1

165,478

Β 

1,096,850

Administrative expenses

(6,501,663)

Β 

(5,142,060)

Other operating (expenses) income

6

(5,679,447)

Β 

(3,404,237)

Goodwill amortization

26

(30,943)

Β 

(30,943)

Intangible assets amortization

27

(24,188)

Β 

(7,774)

Impairment release (charges) for credit losses

(1,216,770)

Β 

(298,078)

Bank's share in the profits / losses of associates

(39,486)

Β 

(16,343)

Profit before income tax

Β 

31,606,522

Β 

17,682,074

Β 

Β 

Income tax expense

28

(9,540,412)

Β 

(4,885,951)

Deferred tax assets (Liabilities)

28

392,680

Β 

(597,241)

Net profit from continued operations

Β 

22,458,790

Β 

12,198,882

Β 

Β 

Discontinued Operations

Β 

Β 

Β 

Net profit (loss) from discontinued operations

31

(49,699)

Β 

-

Net profit for the period

Β 

22,409,091

Β 

12,198,882

Β 

Β 

Non Controlling Interest

3,328

Β 

25,625

Bank's shareholders

Β 

22,405,763

Β 

12,173,257

Β 

Β 

Earnings per share

7

Β 

Β 

Basic

6.41

Β 

3.62

Diluted

6.34

Β 

3.58

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2023

Β 

Last 9 Months

Β 

Last 9 Months

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Net profit for the period

22,409,091

Β 

12,198,882

Β 

Β 

Change in fair value of Financial invesments measured at fair value through comprehensive income after tax

(9,629,911)

Β 

(13,184,005)

Transferred to RE from financial assets at fair value through comprehensive income

(95,308)

Β 

(4,128)

Cumulative foreign currencies translation differences

193,162

Β 

96,867

Effect of ECL in fair value of debt instruments measured at fair value through comprehensive income

201,185

Β 

233,717

Total comprehensive income for the period

Β 

13,078,219

Β 

(658,667)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

As follows:

Bank's shareholders

13,074,891

Β 

(684,292)

Non-Controlling Interest

3,328

Β 

25,625

Total comprehensive income for the period

Β 

13,078,219

Β 

(658,667)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Cash flows for the period ended September 30 2023

Β 

Β 

Notes

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Cash flow from operating activities

Β 

Β 

Β 

Profit before income tax from continued operations

31,606,522

Β 

17,682,074

Profit (loss) from discontinued operations

(49,699)

Β 

-

Adjustments to reconcile profits to net cash provided by operating activities

Β 

Β 

Β 

Fixed assets depreciation

16

655,051

Β 

644,401

Impairment (Released) charge for credit losses (Loans and advances to customers and banks)

1,050,980

Β 

12,998

Other provisions charges

21

2,350,253

Β 

1,803,568

Impairment (Released) charge for credit losses (due from banks)

(47,249)

Β 

534

Impairment (Released) charge for credit losses (financial investments)

213,039

Β 

284,546

Impairment (Released) charge for other assets

14,347

Β 

(277,768)

Exchange revaluation differences for financial assets at fair value through OCI and AC

(5,409,592)

Β 

(3,745,045)

Goodwill amortization

26

30,943

Β 

30,943

Intangible assets amortization

27

24,188

Β 

7,774

Utilization of other provisions

21

(1,608)

Β 

(1,857)

Other provisions no longer used

21

-

Β 

(101)

Exchange Revaluation differences of other provisions

21

1,096,665

Β 

333,425

profits from selling property and equipment

(194)

Β 

(2,192)

profits from selling financial investments at fair value through OCI

13.1

(149,012)

Β 

(1,096,850)

Losses (Profits) from selling investments in associates

13.1

(7,466)

Β 

-

Impairment (Released) charges of investments in associates

13.1

(9,000)

Β 

-

Shares based payments

608,250

Β 

579,653

Bank's share in the profits / losses of associates

39,486

Β 

16,343

Operating profits before changes in operating assets and liabilities

Β 

32,015,904

Β 

16,272,446

Β 

Β 

Net decrease / increase in assets and liabilities

Β 

Β 

Β 

Due from banks

9,859,636

Β 

870,167

Financial assets at fair value through P&L

-

Β 

240,987

Derivative financial instruments

172,635

Β 

(947,321)

Loans and advances to banks and customers

11 - 12

(27,548,758)

Β 

(33,780,208)

Other assets

(2,506,019)

Β 

1,245,185

Non current assets held for sale

(214)

Β 

-

Due to banks

17

15,526,008

Β 

881,371

Due to customers

18

136,052,663

Β 

91,778,069

Current income tax obligations paid

(2,546,958)

Β 

(2,207,579)

Non current liabilities held for sale

933

Β 

-

Other liabilities

(3,890,097)

Β 

(325,379)

Net cash generated from (used in) operating activities

Β 

157,135,733

Β 

74,027,738

Β 

Β 

Cash flow from investing activities

Β 

Β 

Β 

Proceeds from Investments in associates.

2,119

Β 

-

Payment for purchases of property, equipment and branches construction

(1,177,450)

Β 

(556,512)

Proceeds from selling property and equipment

194

Β 

2,192

Proceeds from redemption of financial assets at amortized cost

5,278,030

Β 

6,520,697

Payment for purchases of financial assets at amortized cost

(9,334,085)

Β 

(18,268,602)

Payment for purchases of financial assets at fair value through OCI

(64,860,157)

Β 

(115,077,815)

Proceeds from selling financial assets at fair value through OCI

75,128,566

Β 

73,424,845

Payment for investment in subsidiaries.

(1,008,761)

Β 

-

Net cash generated from (used in) investing activities

Β 

4,028,456

Β 

(53,955,195)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Cash flows for the period ended September 30, 2023 (Cont.)

Β 

Β 

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Other loans

2,408,739

Β 

1,116,344

Dividends paid

(3,594,747)

Β 

(4,410,322)

Issued debt instruments

615,227

Β 

382,977

Capital increase

369,876

Β 

122,716

Net cash generated from (used in) financing activities

Β 

(200,905)

Β 

(2,788,285)

Β 

Β 

Β 

Β 

Β 

Net (decrease) increase in cash and cash equivalent during the period

160,963,284

Β 

17,284,258

Beginning balance of cash and cash equivalent

92,969,526

Β 

61,065,822

Cash and cash equivalent at the end of the period

Β 

253,932,810

Β 

78,350,080

Β 

Β 

Β 

Cash and cash equivalent comprise:

Β 

Β 

Β 

Cash and balances at the central bank

59,950,223

Β 

43,857,708

Due from banks

276,845,003

Β 

90,499,843

Treasury bills

10

71,507,826

Β 

87,122,900

Obligatory reserve balance with CBE

(52,963,236)

Β 

(38,082,441)

Due from banks with maturity more than three months

(30,994,611)

Β 

(22,949,758)

Treasury bills with maturity more than three months

(70,412,395)

Β 

(82,098,172)

Total cash and cash equivalent

Β 

253,932,810

Β 

78,350,080

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim statement of changes in shareholders' equity

Β 

Sep. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Β 

EGP Thousands

Beginning Balance at 1 January 2022

19,702,418

3,293,074

28,260,532

1,550,906

8,183

16,000

641,372

9,141

13,696,402

1,674,392

(4,218)

68,848,202

454,535

69,302,737

Capital increase

10,122,716

-

(10,000,000)

-

-

-

-

-

-

-

-

122,716

-

122,716

Transferred to reserves

-

670,872

8,836,326

-

-

2,947

-

-

(9,007,223)

(502,922)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(4,410,322)

-

-

(4,410,322)

-

(4,410,322)

Net profit for the period

-

-

-

-

-

-

-

-

12,173,257

-

-

12,173,257

25,625

12,198,882

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(4,128)

-

4,128

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(13,184,005)

-

-

-

-

(13,184,005)

-

(13,184,005)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,840

(2,840)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

233,717

-

-

-

-

233,717

-

233,717

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

579,653

-

579,653

-

579,653

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

101,085

101,085

65,507

166,592

Balance at 30 September 2022

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(12,313,044)

11,981

12,453,402

1,751,123

96,867

64,464,303

545,667

65,009,970

Β 

Β 

Β 

Β 

Sep. 30, 2023

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Β 

EGP Thousands

Beginning Balance at 1 January 2023

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(13,188,818)

11,981

16,393,841

1,895,435

181,324

67,757,737

580,431

68,338,168

Capital increase

369,876

-

-

-

-

-

-

-

-

-

-

369,876

-

369,876

Transferred to reserves

-

806,408

12,743,849

-

-

2,208

-

-

(12,388,223)

(1,164,242)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(3,738,888)

-

-

(3,738,888)

(17,108)

(3,755,996)

Net profit for the period

-

-

-

-

-

-

-

-

22,405,763

-

-

22,405,763

3,328

22,409,091

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(95,308)

-

95,308

-

-

-

-

-

Change in non controlling interest from acquisition of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

(536,867)

(536,867)

Reserve for transactions under common control

-

-

-

-

(679,155)

-

-

-

-

-

-

(679,155)

-

(679,155)

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(9,629,911)

-

-

-

-

(9,629,911)

-

(9,629,911)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

3,249

(3,249)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

201,185

-

-

-

-

201,185

-

201,185

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

608,250

-

608,250

-

608,250

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

11,838

11,838

99,192

111,030

Β Balance at 30 September 2023

30,195,010

4,770,354

39,840,707

1,550,906

(670,972)

21,155

(22,712,852)

15,230

22,764,552

1,339,443

193,162

77,306,695

128,976

77,435,671

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRTFSWFWEEDSEIF
Date   Source Headline
23rd May 20138:13 amRNSChanges in CIB's Board of Directors structure
16th May 20137:00 amRNS1st Quarter Results Earning Release
16th May 20137:00 amRNS1st Quarter Results
16th May 20137:00 amRNS1st Quarter Results
21st Mar 20133:40 pmRNSPrice Monitoring Extension
20th Feb 20137:00 amRNSFinal Results
20th Feb 20137:00 amRNSFinal Results
20th Feb 20137:00 amRNSAGM Statement
20th Feb 20137:00 amRNSFinal Results
14th Jan 20137:00 amRNSPress Release regarding new CBE governor
28th Dec 20123:46 pmRNSSecond Price Monitoring Extn
28th Dec 20123:40 pmRNSPrice Monitoring Extension
27th Dec 20123:45 pmRNSSecond Price Monitoring Extn
27th Dec 20123:40 pmRNSPrice Monitoring Extension
14th Nov 20127:00 amRNS3rd Quarter Results Press Release
14th Nov 20127:00 amRNS3rd Quarter Results
14th Nov 20127:00 amRNS3rd Quarter Results
15th Aug 20127:00 amRNS1st Half 2012 earnings release
15th Aug 20127:00 amRNS1st Half 2012 financial statements
15th Aug 20127:00 amRNS1st Half 2012 unconsolidated financial statements
10th May 20127:00 amRNSQ1'2012 Stand-alone Financials
10th May 20127:00 amRNSQ1'2012 Consolidated Financials
10th May 20127:00 amRNSQ1'2012 Press Release
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Consolidated Financials
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Standalone Financials
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Earning Release
1st Dec 20117:00 amRNSPress Release
16th Nov 20117:00 amRNS3rd Quarter Results - Press Release
16th Nov 20117:00 amRNS3rd Quarter Results
16th Nov 20117:00 amRNS3rd Quarter Results
11th Aug 20117:00 amRNSCIB's 1st Half Earnings Release
11th Aug 20117:00 amRNSCIB's 1st Half Unconsolidated Financial Statements
11th Aug 20117:00 amRNSCIB's 1st Half Consolidated Financial Statements
12th May 20117:00 amRNSUnconsolidated 1st Quarter Results
12th May 20117:00 amRNSManagement Comments on 1st Quarter Results
12th May 20117:00 amRNS1st Quarter Results
24th Mar 20111:44 pmRNSNotice of EGM after changing the venue
23rd Mar 20117:33 amRNSNotice of EGM
24th Feb 20117:00 amRNSCIB Press Release regarding 2010 full year results
24th Feb 20117:00 amRNSCIB's 2010 Consolidated year end financial result
24th Feb 20117:00 amRNSCIB 2010 Unconsolidated Year end financial results
11th Nov 20107:00 amRNSManagement Comments on 3rd Quarter results
11th Nov 20107:00 amRNS3rd Quarter Results
11th Nov 20107:00 amRNSCIB Unconsolidated 3rd Quarter Results
11th Aug 20107:00 amRNSCIB 1H 2010 Press Release
11th Aug 20107:00 amRNSStandalone Financial Statements
11th Aug 20107:00 amRNSConsolidated Financial Statements
6th Jul 20107:00 amRNSDividend Declaration
4th Jun 20103:45 pmRNSSecond Price Monitoring Extn
4th Jun 20103:40 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.